LT - Migalastatas, skirtas Fabri ligos pacientų, turinčių inkstų funkcijos sutrikimą, gydymui
EN - MIGALASTAT FOR TREATING FABRY PATIENTS HAVING RENAL IMPAIRMENT
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/445 |
(2006.01) |
|
|
A61P 13/12 |
(2006.01) |
European patent
| (11) |
Number of the document |
3630114 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
18733415.6 |
|
Date of filing the European patent application |
2018-05-30 |
| (97) |
Date of publication of the European application |
2020-04-08 |
| (45) |
Date of publication and mention of the grant of the patent |
2023-11-01
|
| (46) |
Date of publication of the claims translation |
2024-02-12
|
PCT application
| (86) |
Number |
PCT/US2018/035032 |
|
Date |
2018-05-30 |
PCT application publication
| (87) |
Number |
WO 2018/222655 |
|
Date |
2018-12-06 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
201762512458 P |
2017-05-30
|
US |
|
201862626953 P |
2018-02-06
|
US |
Inventors
| (72) |
CASTELLI, Jeff , US
|
Grantee
| (73) |
Amicus Therapeutics, Inc. ,
3675 Market Street, Philadelphia, PA 19104,
US
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
| (54) |
Migalastatas, skirtas Fabri ligos pacientų, turinčių inkstų funkcijos sutrikimą, gydymui |
| |
MIGALASTAT FOR TREATING FABRY PATIENTS HAVING RENAL IMPAIRMENT |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-04-24 |
8 |
185.00
EUR
|
Next renewal fee
|
2026-05-30 |
